System and method for discriminating between atrial and ventricular arrhythmias and for applying cardiac therapy therefor

• US 5,620,471 A
• Filed: 06/16/1995
• Issued: 04/15/1997
• Est. Priority Date: 06/16/1995
• Status: Expired due to Term

• Current Assignee: Pacesetter Incorporated (Abbott Laboratories)
• Original Assignee: Pacesetter Incorporated (Abbott Laboratories)
• Inventors: Duncan, James L.
• Primary Examiner(s): Manuel, George
• Assistant Examiner(s): LAYNO, CARL HERNANDZ
• Application Number:
  US08/491,560
• Time in Patent Office: 669 Days
• Field of Search: 607/9, 607/14, 607/15
• US Class Current: 607/14
• CPC Class Codes: A61N 1/3622 comprising two or more electrodes co-operating with different heart regions

Abstract

Improved methods and apparatus are provided for applying atrial and ventricular therapies to the heart of a patient using an implanted cardiac stimulating device. Atrial and ventricular heart rates are monitored and analyzed to determine whether the patient is suffering from an atrial or ventricular arrhythmia and to determine what type of therapy is appropriate to apply to the heart. Atrial and ventricular heart rates are compared to determine if the ventricular heart rate exceeds the atrial heart rate and to determine whether the ventricular heart Fate is stable. An early atrial stimulation pulse can also be applied to determine whether the ventricular heart rate follows the atrial heart rate. Atrial and ventricular therapies are applied to the heart based on these determinations.

Claims

1. An implantable cardiac stimulating device for monitoring and stimulating the heart of a patient, the cardiac stimulating device comprising:

means for measuring intrinsic atrial and ventricular heart rates;

rate determining means for determining whether the ventricular heart rate is less than, equal to or exceeds the atrial heart rate;

ventricular stimulation means for applying ventricular stimulation therapy to the heart when the rate determining means determines that the ventricular heart rate exceeds the atrial heart rate;

stability determining means for determining whether the ventricular heart rate is stable, wherein a stable ventricular heart rate provides an indication that the rhythm is a tachycardia and an unstable ventricular heart rate provides an indication that the rhythm requires further testing to determine if it is of natural origin;

atrial pulse generating means for applying an atrial stimulation pulse to the heart at a rate slightly faster than the measured intrinsic atrial heart rate;

reset determining means for determining whether the ventricular heart rate is reset by the atrial stimulation pulse, whereby the resetting of the ventricular heart rate provides an indication that the ventricle is tracking the atrium; and

atrial stimulation means for applying atrial stimulation therapy to the heart when;

the stability determining means determines that the ventricular heart rate is stable;

the rate determining means determines that the atrial heart rate is equal to the ventricular heart rate; and

the reset determining means determines that the ventricular heart rate is reset by the atrial stimulation pulse, thereby indicating that the ventricle is tracking the atrium and an atrial arrhythmia is present.

4. The cardiac stimulating device defined in claims 1 or 2, further comprising:

means for activating the stability determining means in response to the rate determining means determining that the ventricular heart rate does not exceed the atrial heart rate.

5. The cardiac stimulating device defined in claims 1 or 2, wherein the ventricular stimulation means further comprises means for applying ventricular stimulation therapy to the heart when:

the stability determining means determines that the ventricular heart rate is stable;

the rate determining means determines that the atrial heart rate is equal to the ventricular heart rate; and

the reset determining means determines that the ventricular heart rate is not reset by the atrial stimulation pulse, thereby indicating that the ventricle is not tracking the atrium and a ventricular tachycardia exists.

6. The cardiac stimulating device defined in claims 1 or 2, wherein the ventricular stimulation means further comprises means for applying ventricular stimulation therapy to the heart when:

the stability determining means determines that the ventricular heart rate is stable; and

the rate determining means determines that the atrial heart rate exceeds the ventricular heart rate, thereby indicating a ventricular arrhythmia is present.

7. The cardiac stimulating device defined in claims 1 or 2, wherein the rate determining means further comprises:

means for determining whether the ventricular heart rate exceeds a first predetermined threshold ventricular heart rate; and

means for determining whether the ventricular heart rate exceeds a second predetermined threshold ventricular heart rate that is greater than the first predetermined threshold ventricular heart rate;

wherein the ventricular stimulation means applies ventricular stimulation therapy when the ventricular heart rate exceeds the second predetermined threshold ventricular heart rate.

2. An implantable cardiac stimulating device for monitoring and stimulating the heart of a patient, the cardiac stimulating device comprising:

means for measuring intrinsic atrial and ventricular heart rates;

rate determining means for determining whether the ventricular heart rate is less than, equal to or exceeds the atrial heart rate;

ventricular stimulation means for applying ventricular stimulation therapy to the heart when the rate determining means determines that the ventricular heart rate exceeds the atrial heart rate;

stability determining means for determining whether the ventricular heart rate is stable, wherein a stable ventricular heart rate provides an indication that the rhythm is a tachycardia and an unstable ventricular heart rate provides an indication that the rhythm requires further testing to determine if it is of natural origin; and

atrial stimulation means for applying atrial stimulation therapy to the heart when;

the stability determining means determines that the ventricular heart rate is not stable; and

the rate determining means determines that the atrial heart rate exceeds the ventricular heart rate, thereby indicating an atrial arrhythmia is present.

3. The cardiac stimulating device defined in claim 2, further comprising:

atrial pulse generating means for applying an atrial stimulation pulse to the heart at a rate slightly faster than the measured intrinsic atrial heart rate; and

reset determining means for determining whether the ventricular heart rate is reset by the atrial stimulation pulse, whereby the resetting of the ventricular heart rate provides an indication that the ventricle is tracking the atrium.

8. An implantable cardiac stimulating device for monitoring and stimulating the heart of a patient, the cardiac stimulating device comprising:

means for measuring intrinsic atrial and ventricular heart rate;

rate determining means for determining whether the atrial heart rate exceeds the ventricular heart rate; and

stability determining means for determining whether the ventricular heart rate is stable;

means for applying ventricular stimulation therapy to the heart when;

the stability determining means determines that the ventricular heart rate is stable; and

the rate determining means determines that the atrial heart rate exceeds the ventricular heart rate;

atrial pulse generating means for applying an atrial pacing pulse to the heart at a rate slightly faster than the measured intrinsic atrial heart rate;

reset determining means for determining whether the ventricular heart rate is reset by the atrial stimulation pulse, whereby the resetting of the ventricular heart rate provides an indication that the ventricle is tracking the atrium; and

means for applying atrial stimulation therapy to the heart when;

the stability determining means determines that the ventricular heart rate is stable;

the rate determining means determines that the atrial heart rate does not exceed the ventricular heart rate; and

the reset determining means determines that the ventricular heart rate is reset by the atrial stimulation pulse, thereby indicating that the ventricle is tracking the atrium and an atrial arrhythmia is present.

10. The cardiac stimulating device defined in claim 8 or 9, further comprising:

means for activating the stability determining means in response to the rate determining means determining that the atrial heart rate is greater than or equal to the ventricular heart rate.

11. The cardiac stimulating device defined in claims 8 or 9, wherein the ventricular stimulation means further comprises means for applying ventricular stimulation therapy to the heart when:

the stability determining means determines that the ventricular heart rate is stable;

the rate determining means determines that the atrial heart rate does not exceed the ventricular heart rate; and

the reset determining means determines that the ventricular heart rate is not reset by the atrial stimulation pulse.

12. The cardiac stimulating device defined in claims 8 or 9, wherein the rate determining means further comprises:

means for determining whether the ventricular heart rate exceeds a first predetermined threshold ventricular heart rate; and

means for determining whether the ventricular heart rate exceeds a second predetermined threshold ventricular heart rate that is greater than the first predetermined threshold ventricular heart rate;

wherein the ventricular stimulation means applies ventricular stimulation therapy whenever the rate determining means determines that the ventricular heart rate exceeds the second predetermined threshold ventricular heart rate.

13. The cardiac stimulating device defined in claims 8 or 9, wherein:

the rate determining means further comprises means for determining whether the ventricular heart rate exceeds the atrial heart rate;

the ventricular stimulation means applies ventricular stimulation therapy when the rate determining means determines that the ventricular heart rate exceeds the atrial heart rate.

9. An implantable cardiac stimulating device for monitoring and stimulating the heart of a patient, the cardiac stimulating device comprising

means for measuring intrinsic atrial and ventricular heart rate;

rate determining means for determining whether the atrial heart rate exceeds the ventricular heart rate; and

stability determining means for determining whether the ventricular heart rate is stable;

means for applying ventricular stimulation therapy to the heart when;

the stability determining means determines that the ventricular heart rate is stable; and

the rate determining means determines that the atrial heart rate exceeds the ventricular heart rate; and

atrial stimulation means for applying atrial stimulation therapy to the heart when;

the stability determining means determines that the ventricular heart rate is not stable; and

the rate determining means determines that the atrial heart rate exceeds the ventricular heart rate, thereby providing an indication that an atrial arrhythmia is present.

14. A method for monitoring and stimulating the heart of a patient with an implantable cardiac stimulating device comprising the steps of:

measuring an atrial heart rate and a ventricular heart rate;

determining whether the ventricular heart rate exceeds the atrial heart rate;

applying ventricular stimulation therapy to the heart when the ventricular heart rate exceeds the atrial heart rate;

determining whether the ventricular heart rate is stable;

determining whether the atrial heart rate exceeds the ventricular heart rate;

applying an atrial pacing pulse to the heart at a rate slightly faster than the measured intrinsic atrial heart rate;

determining whether the ventricular heart rate is reset by the atrial stimulation pulse; and

applying atrial stimulation therapy to the heart when;

the ventricular heart rate is stable;

the atrial heart rate does not exceed the ventricular heart rate; and

the ventricular heart rate is reset by the atrial stimulation pulse.

16. The method defined in claims 14 or 15, further comprising the step of:

triggering the stability determining step whenever the ventricular heart rate does not exceed the atrial heart rate.

17. The method defined in claims 14 or 15, wherein the ventricular stimulation therapy applying step applies therapy to the heart when:

the ventricular heart rate is stable;

the atrial heart rate does not exceed the ventricular heart rate; and

the ventricular heart rate is not reset by the atrial stimulation pulse.

18. The method defined in claims 14 or 15, further comprising the step of supplying ventricular stimulation therapy to the heart when:

the ventricular heart rate is stable; and

the atrial heart rate exceeds the ventricular heart rate.

19. The method defined in claims 14 or 15, further comprising the step of:

determining whether the ventricular heart rate exceeds a first predetermined threshold ventricular heart rate.

20. The method defined in claim 19, further comprising the step of:

determining whether the ventricular heart rate exceeds a second predetermined threshold ventricular heart rate that is greater than the first predetermined threshold ventricular heart rate;

wherein the ventricular stimulation therapy is applied to the heart when the ventricular heart rate exceeds the second predetermined threshold ventricular heart rate.

15. A method for monitoring and stimulating the heart of a patient with an implantable cardiac stimulating device comprising the steps of:

measuring an atrial heart rate and a ventricular heart rate;

determining whether the ventricular heart rate exceeds the atrial heart rate;

applying ventricular stimulation therapy to the heart when the ventricular heart rate exceeds the atrial heart rate;

determining whether the ventricular heart rate is stable;

determining whether the atrial heart rate exceeds the ventricular heart rate; and

applying atrial stimulation therapy to the heart when;

the ventricular heart rate is not stable; and

the atrial heart rate exceeds the ventricular heart rate.

21. A method for monitoring and stimulating the heart of a patient with an implantable cardiac stimulating device comprising the steps of:

measuring an atrial heart rate and a ventricular heart rate;

determining whether the ventricular heart rate is stable;

determining whether the atrial heart rate exceeds the ventricular heart rate;

applying ventricular stimulation therapy to the heart when the ventricular heart rate is stable and the atrial heart rate exceeds the ventricular heart rate;

applying an atrial pacing pulse to the heart;

determining whether the ventricular heart rate is reset by the atrial stimulation pulse; and

applying atrial stimulation therapy to the heart when;

the ventricular heart rate is stable;

the atrial heart rate is equal to the ventricular heart rate; and

the ventricular heart rate is reset by the atrial stimulation pulse.

23. The method defined in claims 21 or 22, further comprising the steps of:

determining whether the ventricular heart rate exceeds a first predetermined threshold ventricular heart rate;

determining whether the ventricular heart rate exceeds a second predetermined threshold ventricular heart rate that is greater than the first predetermined threshold ventricular heart rate; and

applying ventricular stimulation therapy to the heart when the ventricular heart rate exceeds the second predetermined threshold ventricular heart rate.

24. The method defined in claims 21 or 22, further comprising the step of:

determining whether the ventricular heart rate exceeds the atrial heart rate; and

triggering the stability determining step whenever the ventricular heart rate does not exceed the atrial heart rate.

25. The method defined in claims 21 or 22, further comprising the steps of:

applying an atrial stimulation pulse to the heart; and

determining whether the ventricular heart rate is reset by the atrial stimulation pulse.

26. The method defined in claim 25, further comprising the step of applying ventricular stimulation therapy to the heart when:

the ventricular heart rate is stable;

the atrial heart rate is equal to the ventricular heart rate; and

the ventricular heart rate is not reset by the atrial stimulation pulse.

22. A method for monitoring and stimulating the heart of a patient with an implantable cardiac stimulating device comprising the steps of:

measuring an atrial heart rate and a ventricular heart rate;

determining whether the ventricular heart rate is stable;

determining whether the atrial heart rate exceeds the ventricular heart rate;

applying ventricular stimulation therapy to the heart when the ventricular heart rat is stable and the atrial heart rate exceeds the ventricular heart rate; and

applying atrial stimulation therapy to the heart when;

the ventricular heart rate is not stable; and

the atrial heart rate exceeds the ventricular heart rate.